Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Ad-hoc: Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland - 30 December 2021: Cosmo Pharmaceuticals N.V. (SIX: COPN) ('Cosmo') today announced that Ms. Hazel Winchester has been appointed to the position of Head of Investor Relations and will take up the position on the 10th of January, 2022.
About Cosmo Pharmaceuticals Contact End of ad hoc announcement |
Language: | English |
Company: | Cosmo Pharmaceuticals N.V. |
Riverside 2, Sir John Rogerson's | |
Dublin 2 Dublin | |
Ireland | |
Phone: | + 353 1 817 0370 |
E-mail: | info@cosmopharma.com |
Internet: | https://www.cosmopharma.com/ |
ISIN: | NL0011832936 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1263320 |
End of Announcement | EQS News Service |
|
1263320 30-Dec-2021 GMT/BST